Navigation Links
Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
Date:4/29/2009

COMMACK, N.Y., April 29 /PRNewswire-FirstCall/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of Abbott Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.

Dr. Krieger's expertise with Avery breathing pacemakers began in 1981 while he was Chief of Neurological Surgery at the University of Medicine and Dentistry of New Jersey. Based on that initial experience, Dr. Krieger went on to pioneer the reinnervation of the diaphragm through the use of intercostal to phrenic nerve grafts. He reported the first successful use of the technique in Neurosurgery in October, 1994. As a visiting professor, Dr. Krieger has traveled extensively around the world attending grand rounds and assisting other physicians in the development of their local diaphragm pacing programs.

Dr. Krieger most recently served as Clinical Professor in the Department of Neurological Surgery at the USC Keck School of Medicine in Los Angeles. He is currently in private practice in Beverly Hills, CA. As Chief Clinical Liaison, Dr. Krieger will lecture about the indications and latest advances in diaphragm pacing, and be available for clinical discussions regarding potential candidates for the breathing pacemaker.

Linda Towler, CEO, states, "We are honored to have Dr. Krieger join our team. His experience and expertise will be an invaluable addition to the future growth of ABD."

ABOUT ABD

Avery Biomedical Devices, Inc. (ABD) is a privately-held biomedical device manufacturer located on Long Island, New York. It produces the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation. Through its affiliate, Avery Custom Devices, Inc., ABD manufactures high-quality platinum contact electrodes for research projects, clinical trials and commercially distributed medical devices.

ABD is ISO-13485 certified, and an FDA registered manufacturer of Class III medical devices.

Should you know a patient with quadriplegia, central sleep apnea or other condition that may benefit from a breathing pacemaker, or if you are interested in arranging a meeting with Dr. Krieger please contact us.

    CONTACT
    Kenneth R. Aron, V. P. Sales & Marketing
    631-864-1600
    www.averybiomedical.com


'/>"/>
SOURCE Avery Biomedical Devices, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report
2. Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
3. Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
4. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
5. Abbott Hosts Conference Call for First-Quarter Earnings
6. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
7. Abbott to Present at Cowen Annual Health Care Conference
8. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
9. Abbott Completes Acquisition of Advanced Medical Optics
10. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
11. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... ... New patients who have sleep apnea in Aurora, CO, can now ... Sleep apnea is often left untreated because patients are not familiar with common symptoms ... , Dr. Braasch seeks to raise awareness of sleep apnea in Aurora, CO, and ...
(Date:3/27/2017)... WI (PRWEB) , ... March 27, 2017 , ... ... new patients for custom smile makeovers without requiring a referral. Trimble ... orthodontics, gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... Drs. Justin ... Awareness Week by teaching their patients about the key role this treatment plays in ... from an experienced endodontist. To better serve those who need a root canal in ...
(Date:3/27/2017)... Arlington, VA (PRWEB) , ... March 27, 2017 ... ... version 3.0 was transitioned to the OSEHRA popHealth Community in 2014. ... Steering Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member ...
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the European Medicines Agency (EMA) has notified the ... mcg) Marketing Authorisation Application (MAA) has passed validation, ... is underway. The MAA for ARX-04 (known as ...
(Date:3/28/2017)... March 28, 2017 The global ... USD 8.0 billion by 2025, according to a new ... of infectious diseases and cancer is expected to upsurge ... diagnosis over the coming years. In addition, higher number ... and allogenic stem cell therapy, due to adverse effects ...
(Date:3/27/2017)... Summary This report provides all the ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
Breaking Medicine Technology: